Back to search

Article

Hampered AMPK-ULK1 cascade in Alzheimer’s disease (AD) instigates mitochondria dysfunctions and AD-related alterations that are alleviated by metformin

2024-12-28

Abstract excerpt

<h4>Background</h4> Mitochondrial structure and function alterations are key pathological features in Alzheimer’s disease (AD) brains. The adenosine monophosphate-activated protein kinase (AMPK) and its downstream effector Unc-51 like autophagy activating kinase 1 (ULK1) represent a key node controlling mitochondria health, the alteration of which likely contribute to AD development. <h4>Methods</h4> We designed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c10f2f8a-29aa-5f2e-8c7c-b8d7fad010fc
DOI
10.1101/2024.12.28.630598
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hampered AMPK-ULK1 cascade in Alzheimer’s disease (AD) instigates mitochondria dysfunctions and AD-related alterations that are alleviated by metforminDOI 10.1101/2024.12.28.630598
Select a neighboring publication to make it the new centre.